Overexpression of lncRNA AFAP1-AS1 as a diagnostic biomarker in non-small cell lung cancer

Henley SJ, Ward EM, Scott S, Ma J, Anderson RN, Firth AU et al (2020) Annual report to the nation on the status of cancer, part i: national cancer statistics. Cancer 126(10):2225–2249 Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30 Ferronika P, van den Bos H, Taudt A, Spierings DCJ, Saber A, Hiltermann TJN et al (2017) Copy number alterations assessed at the single-cell level revealed mono- and polyclonal seeding patterns of distant metastasis in a small-cell lung cancer patient. Ann Oncol 28(7):1668–1670 Khuder SA (2001) Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer 31(2–3):139–148 Sun S, Schiller JH, Gazdar AF (2007) Lung cancer in never smokers—a different disease. Nat Rev Cancer 7(10):778–790 Vineis P, Airoldi L, Veglia F, Olgiati L, Pastorelli R, Autrup H et al (2005) Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. BMJ 330(7486):277 Saber A, Hiltermann TJN, Kok K, Terpstra MM, de Lange K, Timens W et al (2017) Mutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumors. Carcinogenesis 38(2):144–151 Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008) Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83(5):584–594 Yang Y-R, Zang S-Z, Zhong C-L, Li Y-X, Zhao S-S, Feng X-J (2014) Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol 7(10):6929 Ji D, Zhong X, Jiang X, Leng K, Xu Y, Li Z et al (2018) The role of long non-coding RNA AFAP1-AS1 in human malignant tumors. Pathol Res Pract 214(10):1524–1531 Deng J, Liang Y, Liu C, He S, Wang S (2015) The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients. Biomed Pharmacother 75:8–11 Rajabi A, Riahi A, Shirabadi-Arani H, Moaddab Y, Haghi M, Safaralizadeh R (2020) Overexpression of HOXA-AS2 LncRNA in patients with gastric cancer and its association with helicobacter pylori infection. J Gastrointest Cancer Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z et al (2013) LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res 41(9):4976–4987 Ren S, Wang F, Shen J, Sun Y, Xu W, Lu J et al (2013) Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer 49(13):2949–2959 Yuan SX, Yang F, Yang Y, Tao QF, Zhang J, Huang G et al (2012) Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients’ poor recurrence-free survival after hepatectomy. Hepatology 56(6):2231–2241 Xu T-P, Xia R, Liu X-X, Sun M, Yin L, Chen W-M et al (2014) Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression. J Hematol Oncol. 7(1):63 Qi P, Du X (2013) The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol 26(2):155–165 Lu T, Wang Y, Chen D, Liu J, Jiao W (2018) Potential clinical application of lncRNAs in non-small cell lung cancer. Onco Targets Ther 11:8045–8052 Wei J, Rybczynska AA, Meng P, Terpstra M, Saber A, Sietzema J et al (2020) An all-in-one transcriptome-based assay to identify therapy-guiding genomic aberrations in nonsmall cell lung cancer patients. Cancers (Basel) 12(10):2843 Yang B, Zhang L, Cao Y, Chen S, Cao J, Wu D et al (2017) Overexpression of lncRNA IGFBP4–1 reprograms energy metabolism to promote lung cancer progression. Mol Cancer 16(1):154 Qian H, Chen L, Huang J, Wang X, Ma S, Cui F et al (2018) The lncRNA MIR4435-2HG promotes lung cancer progression by activating β-catenin signalling. J Mol Med 96(8):753–764 Fang Z, Chen W, Yuan Z, Liu X, Jiang H (2018) LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation. Biomed Pharmacother 101:536–542 Zhen Q, Gao L-N, Wang R-F, Chu W-W, Zhang Y-X, Zhao X-J et al (2018) LncRNA DANCR Promotes Lung Cancer by Sequestering miR-216a. Cancer Control 25(1):1073274818769849 Nie W, Ge H-J, Yang X-Q, Sun X, Huang H, Tao X et al (2016) LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett 371(1):99–106 Zhang Q, Li X, Li X, Li X, Chen Z (2018) LncRNA H19 promotes epithelial-mesenchymal transition (EMT) by targeting miR-484 in human lung cancer cells. J Cell Biochem 119(6):4447–4457 Wu W, Bhagat TD, Yang X, Song JH, Cheng Y, Agarwal R et al (2013) Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1 Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology 144(5):956–966 Zhang F, Li J, Xiao H, Zou Y, Liu Y, Huang W (2018) AFAP1-AS1: A novel oncogenic long non-coding RNA in human cancers. Cell Prolif. 51(1):e12397 Zhuang Y, Jiang H, Li H, Dai J, Liu Y, Li Y et al (2017) Down-regulation of long non-coding RNA AFAP1-AS1 inhibits tumor cell growth and invasion in lung adenocarcinoma. Am J Transl Res 9(6):2997 Lu X, Zhou C, Li R, Liang Z, Zhai W, Zhao L et al (2016) Critical role for the long non-coding RNA AFAP1-AS1 in the proliferation and metastasis of hepatocellular carcinoma. Tumor Biol 37(7):9699–9707 Zeng Z, Bo H, Gong Z, Lian Y, Li X, Li X et al (2016) AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis. Tumor Biol 37(1):729–737 Ji D, Zhong X, Jiang X, Leng K, Xu Y, Li Z et al (2018) The role of long non-coding RNA AFAP1-AS1 in human malignant tumors. Pathol Res Pract 214(10):1524–1531 Liu F-T, Xue Q-Z, Zhu P-Q, Luo H-L, Zhang Y, Hao T (2016) Long noncoding RNA AFAP1-AS1, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis. Onco Targets Ther 9:4247–4254 Li W, Li N, Kang X, Shi K (2017) Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer. Clin Chim Acta 475:152–156 Castillo J, Stueve TR, Marconett CN (2017) Intersecting transcriptomic profiling technologies and long non-coding RNA function in lung adenocarcinoma: discovery, mechanisms, and therapeutic applications. Oncotarget 8(46):81538 Han X, Wang L, Ning Y, Li S, Wang Z (2016) Long non-coding RNA AFAP1-AS1 facilitates tumor growth and promotes metastasis in colorectal cancer. Biol Res 49(1):36 Bo H, Gong Z, Zhang W, Li X, Zeng Y, Liao Q et al (2015) Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget 6(24):20404–20418 Lu X, Zhou C, Li R, Deng Y, Zhao L, Zhai W (2017) Long noncoding RNA AFAP1-AS1 promoted tumor growth and invasion in cholangiocarcinoma. Cell Physiol Biochem 42(1):222–230 Shi D, Wu F, Mu S, Hu B, Zhong B, Gao F et al (2019) LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway. J Exp Clin Cancer Res 38(1):375 Yang ZT, An F, Hu JD, Zhao WH (2019) Long noncoding RNA AFAP1-AS1 accelerates the proliferation and metastasis of prostate cancer via inhibiting RBM5 expression. Eur Rev Med Pharmacol Sci 23(8):3284–3290